News

Looking for how to build strong business relationships? Here's a checklist to help you connect more effectively with current and potential partners.

Pediatricians respond to the first successful gene therapy treatment for epidermolysis bullosa.

A daily capsule of a cocktail of probiotics may reduce both the severity symptoms in moderate atopic dermatitis and the need for topical corticosteroids to treat symptom flare ups in children.

Avoiding and treating vascular compromise with hyaluronic acid (HA) injections requires understanding the subtleties of underlying facial anatomy and keeping a well-stocked arsenal of treatments for impending necrosis.

PeDRA and NSP authors new consensus statement for pediatric psoriasis. Interdisciplinary care (dermatologist and pediatricians) is critical. Regular screening for common comorbidities is recommended.

Specific training criteria and phone management policy and procedures to help your dermatology practice blow the competition away.

Litigation is largely due to a practitioner’s lack of training and the lack of informed consent for the patient.

All children, but healthy controls, had a higher likelihood of behavioral issues. ADHD symptoms of attention, hyperactivity and impulse control, were higher in AD children. Quality of life lower in affected children.

A survey of pediatric dermatologists and rheumatologists reveals wide variation in how patients with pediatric morphea are treated.

The American Academy of Dermatology annual meeting - Feb. 16-20 in San Diego - will highlight the status of new systemic treatments for chronic skin conditions, such as moderate-to-severe atopic dermatitis and psoriasis; in addition to new treatments for inflammatory skin conditions. Bookmark this site to follow the developments.

Dermatologists should take ownership of screening patients for mental health concerns associated with their skin condition.

In this article, Drs. Lawrence Eichenfield and Jessica Sprague review some of the most significant findings and developments in pediatric dermatology from the last year beginning with the availability of biologic agents for pediatric psoriasis and atopic dermatitis.

Morgana Colombo, M.D., is partnering with Integrated Dermatology to lead its practice in Reston, Va., according to a news release.

Adam Friedman, M.D., was honored with the Innovations in Residency Training Award by the Journal of Drugs in Dermatology (JDD) at the Orlando Dermatology Aesthetic & Clinical Conference (ODAC) held in January.

The Food and Drug Administration accepted a new drug application for IDP-118 lotion (halobetasol propionate and tazarotene, Ortho Dermatologics), for the topical treatment of plaque psoriasis.

National Psoriasis Foundation has launched a new website specifically designed for the information needs of children and teens who have psoriatic arthritis.

The first patient has been dosed in the phase two study of PR022 (hypochlorous acid, Realm Therapeutics), a topical gel treatment for patients with atopic dermatitis.

Participants at the Aesthetic Academy named Kevin Sadati, D.O., a facial plastic surgeon based in Newport Beach, Calif., Best Aesthetic Doctor at its recent program.

Hologic’s Cynosure division announced the launch of an advanced radiofrequency device that has been cleared by the U.S. Food and Drug Administration to facial fine lines and wrinkles, tighten skin through soft tissue coagulation, and improve the appearance of cellulite.

atmosphere-Healthcare is a new turnkey company that offers a visual platform for medical office environments aimed at reducing stress, anxiety and increasing patient satisfaction.

Cartessa Aesthetics has signed an exclusive deal with Italian corporation DEKA M.E.L.A. to introduce a laser hair removal device to the United States.

Ortho Dermatologics has announced that RETIN-A MICRO® (tretinoin) gel microsphere 0.06% is now available commercially to healthcare professionals.

Evidence does not support use of common treatments for molluscum contagiosum infections. Natural resolution may be best.

Use of the oral beta blocker propranolol for treatment of infantile hemangioma is likely behind sizable increases in resource utilization, but also decreases in the need for surgery.

Despite recommendations to limit the use of oral antibiotics, dermatologists continue to prescribe them in high numbers, according to results of a large, retrospective analysis of U.S. prescribing trends from 2004 to 2013.

A small study finds that the combination of methotrexate and azathioprine is safe and effective as maintenance treatment for patients with moderate-to-severe atopic dermatitis for up to five years.

Moisturizers were described as the “cornerstone of therapy” in atopic dermatitis in the 2014 AAD guidelines for topical therapies in atopic dermatitis, but the products differ greatly by ingredients which can improve the condition or make it worse.

Vitamin D deficiency in children is associated with being overweight while sufficiency is associated with a healthy BMI, researchers reported in December.

Dermatologist evaluations of patient acne photos submitted via smartphone compare favorably to in-person evaluations, a JAMA Dermatology study shows.

Galderma’s patient access program Galderma CareConnect recently passed the 1,000,000 filled prescriptions.